Molecular entity (molecular entity)|Molecular entity||0|CHEBI:23367|Any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity.
Realizable entity (qualifier value)|Realizable entity||0||
Disposition (qualifier value)|Disposition||0||A disposition is particular behaviour which is always exhibited by a material entity.
Molecule (molecular entity)|Molecule||0|CHEBI:25367|Any polyatomic entity that is an electrically neutral entity consisting of more than one atom.
Heteroatomic molecular entity (molecular entity)|Heteroatomic molecular entity||0|CHEBI:37577|A molecular entity consisting of two or more chemical elements.
Ion (molecular entity)|Ion||0|CHEBI:24870|A molecular entity having a net electric charge.
Enzyme inhibitor (qualifier value)|Enzyme inhibitor||0|CHEBI:23924|A substance that combines with an enzyme resulting in prevention of the normal substrate-enzyme combination and the catalytic reaction.
Hydrolase inhibitor (qualifier value)|Hydrolase inhibitor||0|CHEBI:76759|An enzyme inhibitor that interferes with the action of a hydrolase.
Angiogenesis inhibitor (qualifier value)|Angiogenesis inhibitor||0|CHEBI:48422|A compound that antagonizes or inhibits the development of new blood vessels.
Angiotensin-converting enzyme inhibitor (qualifier value)|Angiotensin-converting enzyme inhibitor||0|CHEBI:35457|A compound that interferes with the action of peptidyl-dipeptidase A.
Aromatase inhibitor (qualifier value)|Aromatase inhibitor||0|CHEBI:50790|An enzyme inhibitor which interferes with the action of aromatase,
Bradykinin receptor antagonist (qualifier value)|Bradykinin receptor antagonist||0|CHEBI:68557|An antagonist at the bradykinin receptor.
BRAF inhibitor (qualifier value)|BRAF inhibitor||0|CHEBI:75047|A compound that specifically inhibits human mutant serine/threonine kinase.
Carbonic anhydrase inhibitor (qualifier value)|Carbonic anhydrase inhibitor||0|CHEBI:23018|A hydrolyase inhibitor that interferes with the action of carbonic anhydrase.
Cyclooxygenase 2 inhibitor (qualifier value)|Cyclooxygenase 2 inhibitor||0|CHEBI:50629|
Janus kinase inhibitor (qualifier value)|Janus kinase inhibitor||0|CHEBI:66921|A tyrosine kinase inhibitor that specifically blocks the action of Janus kinase.
Microtubule inhibitor (qualifier value)|Microtubule inhibitor||0|CHEBI:61951|Any compound that interacts with tubulin to inhibit polymerisation of microtubules.
Mitotic inhibitor (qualifier value)|Mitotic inhibitor||0|CHEBI:64911|Any compound that inhibits cell division.
Monoamine oxidase inhibitor (qualifier value)|Monoamine oxidase inhibitor||0|CHEBI:38623|A compound that interferes with the action of monoamine oxidase.
Neuraminidase inhibitor (qualifier value)|Neuraminidase inhibitor||0|CHEBI:52425|A compound which blocks the function of the viral neuraminidase protein.
Nucleotidyltransferase inhibitor (qualifier value)|Nucleotidyltransferase inhibitor||0|CHEBI:76815|A transferase inhibitor that interferes with the action of any nucleotidyltransferase.
Pentosyltransferase inhibitor (qualifier value)|Pentosyltransferase inhibitor||0|CHEBI:76790|A glycosyltransferase inhibitor that interferes with the action of any pentosyltransferase.
Protein kinase inhibitor (qualifier value)|Protein kinase inhibitor||0|CHEBI:37699|A transferase inhibitor that interferes with the action of protein kinases.
Tyrosine kinase inhibitor (qualifier value)|Tyrosine kinase inhibitor||0|CHEBI:38637|A protein kinase inhibitor that interferes with the action of tyrosine kinase.
Proton pump inhibitor (qualifier value)|Proton pump inhibitor||0|CHEBI:49200|A compound that inhibits H,K-ATPase.
Purine nucleoside phosphorylase inhibitor (qualifier value)|Purine nucleoside phosphorylase inhibitor||0|CHEBI:63090|A pentosyltransferase inhibitor that interferes with the action of purine nucleoside phosphorylase.
HIV-1 reverse transcriptase inhibitor (qualifier value)|HIV-1 reverse transcriptase inhibitor||0|CHEBI:53756|A compound which inhibits the activity of HIV-1 reverse transcriptase.
Coagulation factor Xa inhibitor (qualifier value)|Coagulation factor Xa inhibitor||0|CHEBI:68581|A serine endopeptidase inhibitor that interferes with the action of coagulation factor Xa.
Serotonin re-uptake inhibitor (qualifier value)|Serotonin re-uptake inhibitor||0|CHEBI:50949|A compound that specifically inhibits the reuptake of serotonin in the brain.
Serine proteinase inhibitor (qualifier value)|Serine proteinase inhibitor||1|CHEBI:48353|Any protease inhibitor that restricts the action of a serine protease.
Sodium-glucose cotransporter subtype 2 inhibitor (qualifier value)|Sodium-glucose cotransporter subtype 2 inhibitor||0|CHEBI:73273|An inhibitor that interferes with the action of sodium-glucose transport protein subtype 2.
Thymidylate synthase inhibitor (qualifier value)|Thymidylate synthase inhibitor||0|CHEBI:63720|A methyltransferase inhibitor that interferes with the action of thymidylate synthase.
Topoisomerase inhibitor (qualifier value)|Topoisomerase inhibitor||0|CHEBI:70727|An enzyme inhibitor that interferes with the action of any of the topoisomerases.
Transferase inhibitor (qualifier value)|Transferase inhibitor||0|CHEBI:71300|An enzyme inhibitor that interferes with the action of a transferase.
Xanthine oxidase inhibitor (qualifier value)|Xanthine oxidase inhibitor||0|CHEBI:35634|An enzyme inhibitor that interferes with the action of xanthine oxidase.
Serotonergic (qualifier value)|Serotonergic||0|CHEBI:48278|
Tubulin modulator (qualifier value)|Tubulin modulator||0|CHEBI:60832|A compound that interacts with tubulin to inhibit or promote polymerisation of microtubules.
Oxidoreductase inhibitor (qualifier value)|Oxidoreductase inhibitor||0|CHEBI:76725|An enzyme inhibitor which interferes with the action of an oxidoreductase.
Amikacin (molecular entity)|Amikacin||0|CHEBI:2637|
Amikacin disulfate (molecular entity)|Amikacin disulfate||0|CHEBI:2638|
Apramycin (molecular entity)|Apramycin||0|CHEBI:2790|
Gentamicin (molecular entity)|Gentamicin||0|CHEBI:17833|
Kanamycin (molecular entity)|Kanamycin||0|CHEBI:6104|
Neomycin (molecular entity)|Neomycin||0|CHEBI:7507|
Neomycin C (molecular entity)|Neomycin C||0|CHEBI:53634|
Neomycin sulfate (molecular entity)|Neomycin sulfate||0|CHEBI:31635|
Netilmicin (molecular entity)|Netilmicin||0|CHEBI:7528|
Paromomycin (molecular entity)|Paromomycin||0|CHEBI:7934|
Paromomycin sulfate (molecular entity)|Paromomycin sulfate||0|CHEBI:7935|
Spectinomycin (molecular entity)|Spectinomycin||0|CHEBI:9215|
Spectinomycin dihydrochloride (molecular entity)|Spectinomycin dihydrochloride||0|CHEBI:9216|
Streptomycin (molecular entity)|Streptomycin||0|CHEBI:17076|
Tobramycin (molecular entity)|Tobramycin||0|CHEBI:28864|
Aminoglycoside (molecular entity)|Aminoglycoside||0|CHEBI:47779|
Framycetin (molecular entity)|Framycetin||0|CHEBI:7508|
Amikacin(4+) (molecular entity)|Amikacin(4+)||0|CHEBI:84739|
Amino cyclitol glycoside (molecular entity)|Amino cyclitol glycoside||0|CHEBI:22479|
Sulfate salt (molecular entity)|Sulfate salt||0|CHEBI:35175|
Salt (molecular entity)|Salt||0|CHEBI:24866|A salt is an assembly of cations and anions.
Cation (molecular entity)|Cation||0|CHEBI:36916|A monoatomic or polyatomic species having one or more elementary charges of the proton.
Anion (molecular entity)|Anion||0|CHEBI:22563|A monoatomic or polyatomic species having one or more elementary charges of the electron.
Chloride salt (molecular entity)|Chloride salt||0|CHEBI:23114|
Hydrochloride (molecular entity)_|Hydrochloride||0|CHEBI:36807|A salt formally resulting from the reaction of hydrochloric acid with an organic base.
Protein synthesis inhibitor (qualifier value)|Protein synthesis inhibitor||0|CHEBI:48001|A compound which inhibits the synthesis of a protein.
Streptomycin(3+) (molecular entity)|Streptomycin(3+)||0|CHEBI:58007|
Spectinomycin(2+) (molecular entity)|Spectinomycin(2+)||0|CHEBI:77315|
Ammonium ion (molecular entity)|Ammonium ion||0|CHEBI:35274|
Tobramycin(5+) (molecular entity)|Tobramycin(5+)||0|CHEBI:73678|
Isomerase inhibitor (qualifier value)|Isomerase inhibitor||0|CHEBI:75596|An enzyme inhibitor that inhibits the action of an isomerase.
Prostaglandin-endoperoxide synthase inhibitor (qualifier value)|Prostaglandin-endoperoxide synthase inhibitor||0|CHEBI:35544|A substance that combines with cyclooxygenases and prevents its substrate-enzyme combination with arachidonic acid and the formation of icosanoids, prostaglandins, and thromboxanes.
Pathway inhibitor (qualifier value)|Pathway inhibitor||0|CHEBI:76932|An enzyme inhibitor that interferes with one or more steps in a metabolic pathway.
Acrivastine (molecular entity)|Acrivastine||0|CHEBI:83168|
H1-receptor antagonist (qualifier value)|H1-receptor antagonist||1|CHEBI:37955|A substance that selectively binds to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
Histamine antagonist (qualifier value)|Histamine antagonist||0|CHEBI:37956|
Histaminergic (qualifier value)|Histaminergic||0|CHEBI:37957|A substance used for its action on the histaminergic system.
Pyridine derivative (molecular entity)|Pyridine derivative||0|CHEBI:26421|A heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
Monocarboxylic acid (molecular entity)|Monocarboxylic acid||0|CHEBI:25384|
Carboxylic acid (molecular entity)|Carboxylic acid||0|CHEBI:33575|
Alcaftadine (molecular entity)|Alcaftadine||0|CHEBI:71023|
Amlexanox (molecular entity)|Amlexanox||0|CHEBI:31205|
Astemizole (molecular entity)|Astemizole||0|CHEBI:2896|
Azatadine (molecular entity)|Azatadine||0|CHEBI:2946|
Azatadine maleate (molecular entity)|Azatadine maleate||0|CHEBI:2947|
Azelastine (molecular entity)|Azelastine||0|CHEBI:2950|
Azelastine hydrochloride (molecular entity)|Azelastine hydrochloride||0|CHEBI:2951|
Bepotastine (molecular entity)|Bepotastine||0|CHEBI:71204|
Bepotastine besylate (molecular entity)|Bepotastine besylate||0|CHEBI:31281|
Bromazine (molecular entity)|Bromazine||0|CHEBI:59177|
Bromazine hydrochloride (molecular entity)|Bromazine hydrochloride||0|CHEBI:59178|
Brompheniramine (molecular entity)|Brompheniramine||0|CHEBI:3183|
Brompheniramine maleate (molecular entity)|Brompheniramine maleate||0|CHEBI:3184|
Buclizine (molecular entity)|Buclizine||0|CHEBI:3205|
Buclizine dihydrochloride (molecular entity)|Buclizine dihydrochloride||0|CHEBI:61193|
Carbinoxamine (molecular entity)|Carbinoxamine||0|CHEBI:3398|
Carbinoxamine maleate (molecular entity)|Carbinoxamine maleate||0|CHEBI:31353|
Cetirizine (molecular entity)|Cetirizine||0|CHEBI:3561|
Chlorphenamine (molecular entity)|Chlorphenamine||0|CHEBI:52010|
Cinnarizine (molecular entity)|Cinnarizine||0|CHEBI:31403|
Clemastine (molecular entity)|Clemastine||0|CHEBI:3738|
Clemastine fumarate (molecular entity)|Clemastine fumarate||0|CHEBI:3739|
Clemizole (molecular entity)|Clemizole||0|CHEBI:52140|
Cyclizine (molecular entity)|Cyclizine||0|CHEBI:3994|
Piperidine derivative (molecular entity)|Piperidine derivative||0|CHEBI:26151|
Aldehyde (molecular entity)|Aldehyde||0|CHEBI:17478|A compound RC(=O)H, in which a carbonyl group is bonded to one hydrogen atom and to one R group.
Benzimidazole (molecular entity)|Benzimidazole||0|CHEBI:22715|An organic heterocyclic compound containing a benzene ring fused to an imidazole ring.
Maleate salt (molecular entity)|Maleate salt||0|CHEBI:50221|Salts from maleic acid.
(R)-azelastine (molecular entity)|(R)-azelastine||1|CHEBI:55362|
(S)-azelastine (molecular entity)|(S)-azelastine||1|CHEBI:55363|
Platelet aggregation inhibitor (qualifier value)|Platelet aggregation inhibitor||0|CHEBI:50427|A compound which antagonizes or impairs any mechanism leading to blood platelet aggregation.
Phthalazine derivative (molecular entity)|Phthalazine derivative||0|CHEBI:38768|
Bepotastine(1+) (molecular entity)|Bepotastine(1+)||0|CHEBI:71202|
Organosulfonate salt (molecular entity)|Organosulfonate salt||0|CHEBI:64382|Any organic salt prepared using an organosulfonic acid as the acid component.
Cyclizine hydrochloride (molecular entity)|Cyclizine hydrochloride||0|CHEBI:51045|
Cyproheptadine (molecular entity)|Cyproheptadine||0|CHEBI:4046|
Cyproheptadine hydrochloride (molecular entity)|Cyproheptadine hydrochloride||0||
Desloratadine (molecular entity)|Desloratadine||0|CHEBI:291342|
Dexbrompheniramine (molecular entity)|Dexbrompheniramine||0|CHEBI:59269|
Dexbrompheniramine maleate (molecular entity)|Dexbrompheniramine maleate||0|CHEBI:59273|
Dexchlorpheniramine (molecular entity)|Dexchlorpheniramine||0|CHEBI:4464|
Dimenhydrinate (molecular entity)|Dimenhydrinate||0|CHEBI:4604|
Diphenhydramine (molecular entity)|Diphenhydramine||0|CHEBI:4636|
Diphenhydramine hydrochloride (molecular entity)|Diphenhydramine hydrochloride||0|CHEBI:4637|
Diphenylpyraline (molecular entity)|Diphenylpyraline||0|CHEBI:59788|
Doxylamine (molecular entity)|Doxylamine||0|CHEBI:51380|
Emedastine (molecular entity)|Emedastine||0|CHEBI:4779|
Emedastine difumarate (molecular entity)|Emedastine difumarate||0|CHEBI:59865|
Epinastine (molecular entity)|Epinastine||0|CHEBI:51032|
Epinastine hydrochloride (molecular entity)|Epinastine hydrochloride||0|CHEBI:51037|
Fexofenadine (molecular entity)|Fexofenadine||0|CHEBI:5050|
Hydroxyzine (molecular entity)|Hydroxyzine||0|CHEBI:5818|
Hydroxyzine hydrochloride (molecular entity)|Hydroxyzine hydrochloride||0|CHEBI:5819|
Hydroxyzine pamoate (molecular entity)|Hydroxyzine pamoate||0|CHEBI:31680|
Methapyrilene (molecular entity)|Methapyrilene||0|CHEBI:6820|
Nedocromil (molecular entity)|Nedocromil||0|CHEBI:7492|
Nedocromil sodium (molecular entity)|Nedocromil sodium||0|CHEBI:7493|
Pizotifen (molecular entity)|Pizotifen||0|CHEBI:50212|
Promethazine (molecular entity)|Promethazine||0|CHEBI:8461|
Promethazine hydrochloride (molecular entity)|Promethazine hydrochloride||0|CHEBI:8462|
Trimethobenzamide (molecular entity)|Trimethobenzamide||0|CHEBI:27796|
Triprolidine (molecular entity)|Triprolidine||0|CHEBI:84116|
Triprolidine hydrochloride (molecular entity)|Triprolidine hydrochloride||0||
Monochlorobenzene derivative (molecular entity)|Monochlorobenzene derivative||0|CHEBI:83403|Any member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
Chlorobenzene derivative (qualifier value)|Chlorobenzene derivative||0|CHEBI:23132|Any organochlorine compound containing a benzene ring which is substituted by one or more chlorines.
Benzene derivative (molecular entity)|Benzene derivative||0|CHEBI:22712|
Ether derivative (molecular entity)|Ether derivative||0|CHEBI:25698|An organooxygen compound with formula ROR, where R is not hydrogen.
Muscarinic antagonist (qualifier value)|Muscarinic antagonist||0|CHEBI:48876|A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists.
Cholinergic antagonist (qualifier value)|Cholinergic antagonist||0|CHEBI:48873|Any drug that binds to but does not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists.
Cholinergic (qualifier value)|Cholinergic||0|CHEBI:38323|Any drug used for its actions on cholinergic systems.
(R)-bromazine (molecular entity)|(R)-bromazine||1|CHEBI:59301|
(R)-bromazine hydrochloride (molecular entity)|(R)-bromazine hydrochloride||1|CHEBI:59304|
(S)-bromazine (molecular entity)|(S)-bromazine||1|CHEBI:59302|
(S)-bromazine hydrochloride (molecular entity)|(S)-bromazine hydrochloride||1|CHEBI:59305|
Fumarate salt (molecular entity)|Fumarate salt||0|CHEBI:50921|An organic salt derived from fumaric acid.
Pyrrolidine derivative (molecular entity)|Pyrrolidine derivative||0|CHEBI:38260|Any of a class of heterocyclic amines having a saturated five-membered ring.
N-alkylpyrrolidine derivative (molecular entity)|N-alkylpyrrolidine derivative||0|CHEBI:46775|
R-epinastine (molecular entity)|R-epinastine||1|CHEBI:51035|
S-epinastine (molecular entity)|S-epinastine||1|CHEBI:51036|
Diphenylpyraline hydrochloride (molecular entity)|Diphenylpyraline hydrochloride||0|CHEBI:31508|
Promethazine(1+) (molecular entity)|Promethazine(1+)||0|CHEBI:61214|
Pizotifen maleate (molecular entity)|Pizotifen maleate||0|CHEBI:50214|
Pizotifen(1+) (molecular entity)|Pizotifen(1+)||0|CHEBI:50214|
Pizotifen malate (molecular entity)|Pizotifen malate||0|CHEBI:50213|
Malate salt (molecular entity)|Malate salt||0|CHEBI:50220|
Serotonergic antagonist (qualifier value)|Serotonergic antagonist||0|CHEBI:48279|Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
Piperazine derivative (molecular entity)|Piperazine derivative||0|CHEBI:26144|
N-alkylpiperazine derivative (qualifier value)|N-alkylpiperazine derivative||1|CHEBI:46845|
Buclizine(2+) (molecular entity)|Buclizine(2+)||0|CHEBI:61192|
Benzamide derivative (molecular entity)|Benzamide derivative||0|CHEBI:22702|An aromatic amide that consists of benzene bearing a single carboxamido substituent.
Triprolidine(1+) (molecular entity)|Triprolidine(1+)||0|CHEBI:84117|
Benzazepine derivative (molecular entity)|Benzazepine derivative||0|CHEBI:35676|A group of two-ring heterocyclic compounds consisting of a benzene ring fused to an azepine ring.
Clemizole(1+) (molecular entity)|Clemizole(1+)||0|CHEBI:52146|
Guanidine derivative (molecular entity)|Guanidine derivative||0|CHEBI:24436|Any organonitrogen compound containing a carbamimidamido (guanidino) group.
Phenothiazine derivative (molecular entity)|Phenothiazine derivative||0|CHEBI:38093|
Sodium salt (molecular entity)|Sodium salt||0|CHEBI:26714|Any alkali metal salt having sodium(1+) as the cation.
Nedocromil(2-) (molecular entity)|Nedocromil(2-)||0|CHEBI:51029|
Dicarboxylic acid (molecular entity)|Dicarboxylic acid||0|CHEBI:35692|An oxoacid containing two carboxy groups.
Carboxylic acid anion (molecular entity)|Carboxylic acid anion||0|CHEBI:29067|The conjugate base formed when the carboxy group of a carboxylic acid is deprotonated.
Azithromycin (molecular entity)|Azithromycin||0|CHEBI:2955|
Azithromycin dihydrate (molecular entity)|Azithromycin dihydrate||0|CHEBI:34546|
Clarithromycin (molecular entity)|Clarithromycin||0|CHEBI:3732|
Dirithromycin (molecular entity)|Dirithromycin||0|CHEBI:474014|
Erythromycin (molecular entity)|Erythromycin||0|CHEBI:48923|
Erythromycin estolate (molecular entity)|Erythromycin estolate||0|CHEBI:4846|
Fidaxomicin (molecular entity)|Fidaxomicin||0|CHEBI:68590|
Oleandomycin (molecular entity)|Oleandomycin||0|CHEBI:16869|
Roxithromycin (molecular entity)|Roxithromycin||0|CHEBI:48844|
Amoxicillin (molecular entity)|Amoxicillin||0|CHEBI:2676|
Amoxicillin sodium (molecular entity)|Amoxicillin sodium||0|CHEBI:51255|
Amoxicillin trihydrate (molecular entity)|Amoxicillin trihydrate||0|CHEBI:51254|
Ampicillin (molecular entity)|Ampicillin||0|CHEBI:28971|
Ampicillin sodium (molecular entity)|Ampicillin sodium||0|CHEBI:34535|
Ampicillin trihydrate (molecular entity)|Ampicillin trihydrate||0|CHEBI:31209|
Antipseudomonal penicillin (molecular entity)|Antipseudomonal penicillin||0||
Azlocillin (molecular entity)|Azlocillin||0|CHEBI:2956|
Azlocillin sodium (molecular entity)|Azlocillin sodium||0|CHEBI:51864|
Aztreonam (molecular entity)|Aztreonam||0|CHEBI:161680|
Bacampicillin (molecular entity)|Bacampicillin||0|CHEBI:2968|
Bacampicillin hydrochloride (molecular entity)|Bacampicillin hydrochloride||0|CHEBI:2969|
Benzylpenicillin (molecular entity)|Benzylpenicillin|Penicillin G|0|CHEBI:18208|
Broad spectrum penicillin (molecular entity)|Broad spectrum penicillin||0||
Carbapenem (molecular entity)|Carbapenem||0|CHEBI:46765|
Carbenicillin (molecular entity)|Carbenicillin||0|CHEBI:3393|
Carbenicillin disodium (molecular entity)|Carbenicillin disodium||0|CHEBI:34609|
Carfecillin (molecular entity)|Carfecillin||0|CHEBI:3414|
Carfecillin sodium (molecular entity)|Carfecillin sodium||0|CHEBI:34612|
Cefaclor (molecular entity)|Cefaclor||0|CHEBI:3478|
Cefadroxil (molecular entity)|Cefadroxil||0|CHEBI:3479|
Cefadroxil monohydrate (molecular entity)|Cefadroxil monohydrate||0|CHEBI:53667|
Cefamandole (molecular entity)|Cefamandole||0|CHEBI:3480|
Cefamandole nafate (molecular entity)|Cefamandole nafate||0|CHEBI:3481|
Cefdinir (molecular entity)|Cefdinir||0|CHEBI:3485|
Cefditoren pivoxil (molecular entity)|Cefditoren pivoxil||0|CHEBI:560555|
Cefepime (molecular entity)|Cefepime||0|CHEBI:478164|
Cefepime hydrochloride (molecular entity)|Cefepime hydrochloride||0|CHEBI:31368|
Cefixime (molecular entity)|Cefixime||0|CHEBI:472657|
Cefmetazole (molecular entity)|Cefmetazole||0|CHEBI:3489|
Cefmetazole sodium (molecular entity)|Cefmetazole sodium||0|CHEBI:3490|
Cefodizime (molecular entity)|Cefodizime||0|CHEBI:63214|
Cefonicid (molecular entity)|Cefonicid||0|CHEBI:3491|
Cefonicid sodium (molecular entity)|Cefonicid sodium||0|CHEBI:3492|
Cefoperazone (molecular entity)|Cefoperazone||0|CHEBI:3493|
Ceforanide (molecular entity)|Ceforanide||0|CHEBI:3495|
Cefotaxime (molecular entity)|Cefotaxime||0|CHEBI:204928|
Cefotaxime sodium (molecular entity)|Cefotaxime sodium||0|CHEBI:3498|
Cefotetan (molecular entity)|Cefotetan||0|CHEBI:3499|
Cefotetan disodium (molecular entity)|Cefotetan disodium||0|CHEBI:34617|
Cefotiam (molecular entity)|Cefotiam||0|CHEBI:355510|
Cefoxitin (molecular entity)|Cefoxitin||0|CHEBI:209807|
Cefpodoxime (molecular entity)|Cefpodoxime||0|CHEBI:3504|
Cefpodoxime proxetil (molecular entity)|Cefpodoxime proxetil||0|CHEBI:3505|
Cefprozil (molecular entity)|Cefprozil||0|CHEBI:3506|
Cefsulodin (molecular entity)|Cefsulodin||0|CHEBI:3507|
Ceftaroline (molecular entity)|Ceftaroline||0|CHEBI:70729|
Ceftaroline fosamil (molecular entity)|Ceftaroline fosamil||0|CHEBI:70718|
Ceftazidime (molecular entity)|Ceftazidime||0|CHEBI:3508|
Ceftibuten (molecular entity)|Ceftibuten||0|CHEBI:3510|
Ceftizoxime (molecular entity)|Ceftizoxime||0|CHEBI:553473|
Ceftizoxime sodium (molecular entity)|Ceftizoxime sodium||0|CHEBI:3512|
Ceftriaxone (molecular entity)|Ceftriaxone||0|CHEBI:29007|
Cefuroxime (molecular entity)|Cefuroxime||0|CHEBI:3515|
Cephalexin (molecular entity)|Cephalexin||0|CHEBI:3534|
Cephalexin monohydrate (molecular entity)|Cephalexin monohydrate||0|CHEBI:3535|
Cephaloglycin (molecular entity)|Cephaloglycin||0|CHEBI:34613|
Cephaloridine (molecular entity)|Cephaloridine||0|CHEBI:3537|
Cephalosporin (molecular entity)|Cephalosporin||0|CHEBI:23066|
Cephalothin (molecular entity)|Cephalothin||0|CHEBI:124991|
Cephalothin sodium (molecular entity)|Cephalothin sodium||0|CHEBI:3542|
Cephamycin (molecular entity)|Cephamycin||0|CHEBI:55429|
Cephapirin (molecular entity)|Cephapirin||0|CHEBI:554446|
Cephapirin sodium (molecular entity)|Cephapirin sodium||0|CHEBI:3545|
Cefazolin (molecular entity)|Cefazolin||0|CHEBI:474053|
Cefazolin sodium (molecular entity)|Cefazolin sodium||0|CHEBI:3483|
Cephradine (molecular entity)|Cephradine||0|CHEBI:3547|
Clavulanic acid (molecular entity)|Clavulanic acid||0|CHEBI:48947|
Cloxacillin (molecular entity)|Cloxacillin||0|CHEBI:49566|
Cloxacillin benzathine (molecular entity)|Cloxacillin benzathine||0|CHEBI:51351|
Cloxacillin sodium (molecular entity)|Cloxacillin sodium||0|CHEBI:51357|
Cyclacillin (molecular entity)|Cyclacillin||0|CHEBI:31444|
Dicloxacillin (molecular entity)|Dicloxacillin||0|CHEBI:4511|
Dicloxacillin sodium (molecular entity)|Dicloxacillin sodium||0|CHEBI:34691|
Epicillin (molecular entity)|Epicillin||0|CHEBI:58974|
Ertapenem (molecular entity)|Ertapenem||0|CHEBI:404903|
Ertapenem sodium (molecular entity)|Ertapenem sodium||0|CHEBI:60070|
Extended spectrum penicillin (molecular entity)|Extended spectrum penicillin||0||
First generation cephalosporin (molecular entity)|First generation cephalosporin||0||
Flucloxacillin sodium (molecular entity)|Flucloxacillin sodium|Floxacillin sodium|0|CHEBI:52040|
Fourth generation cephalosporin (molecular entity)|Fourth generation cephalosporin||0||
Hetacillin (molecular entity)|Hetacillin||0|CHEBI:5683|
Imipenem (molecular entity)|Imipenem||0|CHEBI:471744|
Loracarbef (molecular entity)|Loracarbef||0|CHEBI:47544|
Meropenem (molecular entity)|Meropenem||0|CHEBI:43968|
Methicillin (molecular entity)|Methicillin||0|CHEBI:6827|
Methicillin sodium (molecular entity)|Methicillin sodium||0|CHEBI:52065|
Mezlocillin (molecular entity)|Mezlocillin||0|CHEBI:6919|
Mezlocillin sodium (molecular entity)|Mezlocillin sodium||0|CHEBI:52067|
Monobactam (molecular entity)|Monobactam||0|CHEBI:50695|
Moxalactam (molecular entity)|Moxalactam||0|CHEBI:599928|
Nafcillin (molecular entity)|Nafcillin||0|CHEBI:7447|
Nafcillin sodium (molecular entity)|Nafcillin sodium||0|CHEBI:7448|
Natural penicillin (molecular entity)|Natural penicillin||0||
Oxacillin (molecular entity)|Oxacillin||0|CHEBI:7809|
Oxacillin sodium (molecular entity)|Oxacillin sodium||0|CHEBI:52134|
Penicillin (molecular entity)|Penicillin||0|CHEBI:17334|Any member of the group of substituted penams containing two methyl substituents at position 2, a carboxylate substituent at position 3 and a carboxamido group at position 6.
Benzylpenicillin benzathine (molecular entity)|Benzylpenicillin benzathine|Penicillin G benzathine|0|CHEBI:51352|
Benzylpenicillin potassium (molecular entity)|Benzylpenicillin potassium|Penicillin G potassium|0|CHEBI:7963|
Benzylpenicillin sodium (molecular entity)|Benzylpenicillin sodium|Penicillin G sodium|0|CHEBI:51765|
Phenoxymethylpenicillin (molecular entity)|Phenoxymethylpenicillin|Penicillin V|0|CHEBI:27446|
Phenoxymethylpenicillin potassium (molecular entity)|Phenoxymethylpenicillin potassium|Penicillin V potassium|0|CHEBI:7967|
Penicillinase sensitive penicillin (molecular entity)|Penicillinase sensitive penicillin||0||
Penicillinase-resistant penicillin (molecular entity)|Penicillinase-resistant penicillin||0||
Phenethicillin (molecular entity)|Phenethicillin||0|CHEBI:52427|
Piperacillin (molecular entity)|Piperacillin||0|CHEBI:8232|
Piperacillin sodium (molecular entity)|Piperacillin sodium||0|CHEBI:8233|
Pivampicillin (molecular entity)|Pivampicillin||0|CHEBI:51210|
Pivmecillinam hydrochloride (molecular entity)|Pivmecillinam hydrochloride||0|CHEBI:51213|
Second generation cephalosporin (molecular entity)|Second generation cephalosporin||0||
Talampicillin (molecular entity)|Talampicillin||0|CHEBI:9391|
Talampicillin hydrochloride (molecular entity)|Talampicillin hydrochloride||0|CHEBI:34993|
Temocillin (molecular entity)|Temocillin||0|CHEBI:51817|
Temocillin sodium (molecular entity)|Temocillin sodium||0|CHEBI:52434|
Third generation cephalosporin (molecular entity)|Third generation cephalosporin||0||
Ticarcillin (molecular entity)|Ticarcillin||0|CHEBI:9587|
Ticarcillin disodium (molecular entity)|Ticarcillin disodium||0|CHEBI:35017|
Ticarcillin(2-) (molecular entity)|Ticarcillin(2-)||0|CHEBI:51811|
Temocillin(2-) (molecular entity)|Temocillin(2-)||0|CHEBI:52438|
Piperacillin(1-) (molecular entity)|Piperacillin(1-)||0|CHEBI:52433|
Amoxicillin(1-) (molecular entity)|Amoxicillin(1-)||0|CHEBI:51256|
Ampicillin(1-) (molecular entity)|Ampicillin(1-)||0|CHEBI:50658|
Azlocillin(1-) (molecular entity)|Azlocillin(1-)||0|CHEBI:51863|
Benzylpenicillin(1-) (molecular entity)|Benzylpenicillin(1-)||0|CHEBI:51354|
Carbenicillin(2-) (molecular entity)|Carbenicillin(2-)||0|CHEBI:51897|
Carfecillin(1-) (molecular entity)|Carfecillin(1-)||0|CHEBI:51906|
Cefazolin(1-) (molecular entity)|Cefazolin(1-)||0|CHEBI:53657|
Cefepime(1+) (molecular entity)|Cefepime(1+)||0|CHEBI:59349|
Cefmetazole(1-) (molecular entity)|Cefmetazole(1-)||0|CHEBI:52439|
Cefonicid(2-) (molecular entity)|Cefonicid(2-)||0|CHEBI:52441|
Cefotetan(2-) (molecular entity)|Cefotetan(2-)||0|CHEBI:59358|
Ceftizoxime(1-) (molecular entity)|Ceftizoxime(1-)||0|CHEBI:55498|
Cephapirin(1-) (molecular entity)|Cephapirin(1-)||0|CHEBI:59217|
Cloxacillin(1-) (molecular entity)|Cloxacillin(1-)||0|CHEBI:51350|
Dicloxacillin(1-) (molecular entity)|Dicloxacillin(1-)||0|CHEBI:52017|
Ertapenem(1-) (molecular entity)|Ertapenem(1-)||0|CHEBI:60071|
Methicillin(1-) (molecular entity)|Methicillin(1-)||0|CHEBI:52064|
Mezlocillin(1-) (molecular entity)|Mezlocillin(1-)||0|CHEBI:52066|
Nafcillin(1-) (molecular entity)|Nafcillin(1-)||0|CHEBI:51918|
Oxacillin(1-) (molecular entity)|Oxacillin(1-)||0|CHEBI:52132|
Phenoxymethylpenicillin(1-) (molecular entity)|Phenoxymethylpenicillin(1-)||0|CHEBI:51355|
Cefotaxime(1-) (molecular entity)|Cefotaxime(1-)||0|CHEBI:53670|
Lactam (molecular entity)|Lactam||0|CHEBI:24995|
Beta-lactam (molecular entity)|Beta-lactam||0|CHEBI:35627|
Thiophene (molecular entity)|Thiophene||0|CHEBI:26961|Compounds containing at least one thiophene ring.
Thiadiazole derivative (molecular entity)|Thiadiazole derivative||0|CHEBI:38099|
(E)-roxithromycin (molecular entity)|(E)-roxithromycin||1|CHEBI:48935|
(Z)-roxithromycin (molecular entity)|(Z)-roxithromycin||1|CHEBI:32109|
Pyrrolidinecarboxamide (molecular entity)|Pyrrolidinecarboxamide||0|CHEBI:46770|
Macrolide (molecular entity)|Macrolide||0|CHEBI:25106|
Hydrate (molecular entity)|Hydrate||0|CHEBI:35505|
Cephem (molecular entity)|Cephem||0|CHEBI:38311|
Penam (molecular entity)|Penam||0|CHEBI:35992|Natural and synthetic antibiotics containing the 4-thia-1-azabicyclo[3.2.0]heptan-7-one structure.
Azole (molecular entity)|Azole||0|CHEBI:68452|Any monocyclic heteroarene consisting of a five-membered ring containing nitrogen.
Thiazole (molecular entity)|Thiazole||0|CHEBI:48901|
Carboxylic ester (molecular entity)|Carboxylic ester||0|CHEBI:33308|An ester of a carboxylic acid.
Phenethicillin(1-) (molecular entity)|Phenethicillin(1-)||0|CHEBI:52428|
Oleandomycin(1+) (molecular entity)|Oleandomycin(1+)||0|CHEBI:57933|
Potassium salt (molecular entity)|Potassium salt||0|CHEBI:50394|
Cefditoren (molecular entity)|Cefditoren||0|CHEBI:59343|
Mecillinam (molecular entity)|Mecillinam||0|CHEBI:51208|
Triazine derivative (molecular entity)|Triazine derivative||0|CHEBI:38102|
Benzathine salt (molecular entity)|Benzathine salt||0|CHEBI:51347|
Ester (molecular entity)|Ester||0|CHEBI:35701|
Nadifloxacin (molecular entity)|Nadifloxacin||0|CHEBI:31889|
Moxifloxacin (molecular entity)|Moxifloxacin||0|CHEBI:63611|
Gemifloxacin (molecular entity)|Gemifloxacin||0|CHEBI:101853|
Temafloxacin (molecular entity)|Temafloxacin||0|CHEBI:77788|
Sparfloxacin (molecular entity)|Sparfloxacin||0|CHEBI:9212|
Lomefloxacin (molecular entity)|Lomefloxacin||0|CHEBI:116278|
Levofloxacin (molecular entity)|Levofloxacin||0|CHEBI:63598|
Ofloxacin (molecular entity)|Ofloxacin||0|CHEBI:7731|
Norfloxacin (molecular entity)|Norfloxacin||0|CHEBI:100246|
Ciprofloxacin (molecular entity)|Ciprofloxacin||0|CHEBI:100241|
Trovafloxacin (molecular entity)|Trovafloxacin||0|CHEBI:9763|
Pefloxacin (molecular entity)|Pefloxacin||0|CHEBI:50199|
Enrofloxacin (molecular entity)|Enrofloxacin||0|CHEBI:35720|
Gatifloxacin (molecular entity)|Gatifloxacin||0|CHEBI:5280|
Moxifloxacin hydrochloride (molecular entity)|Moxifloxacin hydrochloride||0|CHEBI:7008|
Gemifloxacin mesylate (molecular entity)|Gemifloxacin mesylate||0|CHEBI:53749|
Lomefloxacin hydrochloride (molecular entity)|Lomefloxacin hydrochloride||0|v|
Ciprofloxacin dihydrochloride (molecular entity)|Ciprofloxacin dihydrochloride||0|CHEBI:59938|
Trovafloxacin mesylate (molecular entity)|Trovafloxacin mesylate||0|CHEBI:77568|
Flucloxacillin (molecular entity)|Flucloxacillin|Floxacillin|0|CHEBI:5098|
Butirosin (molecular entity)|Butirosin||0|CHEBI:65109|
Chloramphenicol (molecular entity)|Chloramphenicol||0|CHEBI:17698|
Cinoxacin (molecular entity)|Cinoxacin||0|CHEBI:3716|
Clindamycin (molecular entity)|Clindamycin||0|CHEBI:3745|
Clofazimine (molecular entity)|Clofazimine||0|CHEBI:3749|
Clomocycline (molecular entity)|Clomocycline||0|CHEBI:59589|
Colistimethate (molecular entity)|Colistimethate||0|CHEBI:59662|
Colistimethate sodium (molecular entity)|Colistimethate sodium||0|CHEBI:34650|
Colistin (molecular entity)|Colistin||0|CHEBI:37943|
Daptomycin (molecular entity)|Daptomycin||0|CHEBI:600103|
Demeclocycline (molecular entity)|Demeclocycline||0|CHEBI:4392|
Demeclocycline hydrochloride (molecular entity)|Demeclocycline hydrochloride||0|CHEBI:59725|
Doxycycline (molecular entity)|Doxycycline||0|CHEBI:50845|
Doxycycline hyclate (molecular entity)|Doxycycline hyclate||0|CHEBI:34730|
Doxycycline monohydrate (molecular entity)|Doxycycline monohydrate||0|CHEBI:60648|
Enoxacin (molecular entity)|Enoxacin||0|CHEBI:157175|
Ethambutol (molecular entity)|Ethambutol||0|CHEBI:4877|
Ethambutol dihydrochloride (molecular entity)|Ethambutol dihydrochloride||0|CHEBI:4878|
Ethionamide (molecular entity)|Ethionamide||0|CHEBI:4885|
Fosfomycin (molecular entity)|Fosfomycin||0|CHEBI:28915|
Fumagillin (molecular entity)|Fumagillin||0|CHEBI:48635|
Furazolidone (molecular entity)|Furazolidone||0|CHEBI:5195|
Fusidic acid (molecular entity)|Fusidic acid||0|CHEBI:29013|
Lincomycin (molecular entity)|Lincomycin||0|CHEBI:6472|
Linezolid (molecular entity)|Linezolid||0|CHEBI:63607|
Lymecycline (molecular entity)|Lymecycline||0|CHEBI:59040|
Mandelic acid (molecular entity)|Mandelic acid||0|CHEBI:35825|
Metronidazole (molecular entity)|Metronidazole||0|CHEBI:6909|
Methacycline (molecular entity)|Methacycline||0|CHEBI:6805|
Metronidazole benzoate (molecular entity)|Metronidazole benzoate||0|CHEBI:50688|
Metronidazole hydrochloride (molecular entity)|Metronidazole hydrochloride||0|CHEBI:50687|
Minocycline (molecular entity)|Minocycline||0|CHEBI:50694|
Minocycline hydrochloride (molecular entity)|Minocycline hydrochloride||0|CHEBI:50697|
Mupirocin (molecular entity)|Mupirocin||0|CHEBI:7025|
Nalidixic acid (molecular entity)|Nalidixic acid||0|CHEBI:100147|
Neamine (molecular entity)|Neamine||0|CHEBI:7489|
Nitrofurantoin (molecular entity)|Nitrofurantoin||0|CHEBI:71415|
Novobiocin (molecular entity)|Novobiocin||0|CHEBI:28368|
Ornidazole (molecular entity)|Ornidazole||0|CHEBI:75176|
Oxazolidinone (molecular entity)|Oxazolidinone||0|CHEBI:55374|
Oxytetracycline (molecular entity)|Oxytetracycline||0|CHEBI:27701|
Pipemidic acid (molecular entity)|Pipemidic acid||0|CHEBI:75250|
Polymyxin (molecular entity)|Polymyxin||0|CHEBI:59062|Compound with a general structure consisting of a cyclic peptide with a long hydrophobic tail.
Pyrazinamide (molecular entity)|Pyrazinamide||0|CHEBI:45285|
Quinolone (molecular entity)|Quinolone||0|CHEBI:23765|
Rifabutin (molecular entity)|Rifabutin||0|CHEBI:45367|
Rifampicin (molecular entity)|Rifampicin||0|CHEBI:28077|
Rifamycin (molecular entity)|Rifamycin||0|CHEBI:26580|
Rifapentine (molecular entity)|Rifapentine||0|CHEBI:45304|
Rifaximin (molecular entity)|Rifaximin||0|CHEBI:75246|
Rolitetracycline (molecular entity)|Rolitetracycline||0|CHEBI:63334|
Silver sulfadiazine (molecular entity)|Silver sulfadiazine||0|CHEBI:9142|
Sisomicin (molecular entity)|Sisomicin||0|CHEBI:9169|
Sulfacetamide (molecular entity)|Sulfacetamide||0|CHEBI:63845|
Sulfacetamide sodium (molecular entity)|Sulfacetamide sodium||0|CHEBI:63858|
Sulfachlorpyridazine (molecular entity)|Sulfachlorpyridazine||0|CHEBI:59057|
Sulfadiazine (molecular entity)|Sulfadiazine||0|CHEBI:9328|
Sulfadimethoxine (molecular entity)|Sulfadimethoxine||0|CHEBI:32161|
Sulfadoxine (molecular entity)|Sulfadoxine||0|CHEBI:9329|
Sulfamerazine (molecular entity)|Sulfamerazine||0|CHEBI:102130|
Sulfamethoxydiazine (molecular entity)|Sulfamethoxydiazine||0|CHEBI:53727|
Sulfamethazine (molecular entity)|Sulfamethazine||0|CHEBI:102265|
Sulfamethizole (molecular entity)|Sulfamethizole||0|CHEBI:9331|
Sulfamethoxazole (molecular entity)|Sulfamethoxazole||0|CHEBI:9332|
Sulfamethoxypyridazine (molecular entity)|Sulfamethoxypyridazine||0|CHEBI:102516|
Sulfamoxole (molecular entity)|Sulfamoxole||0|CHEBI:55548|
Sulfanilamide (molecular entity)|Sulfanilamide||0|CHEBI:45373|
Sulfaphenazole (molecular entity)|Sulfaphenazole||0|CHEBI:77780|
Sulfapyridine (molecular entity)|Sulfapyridine||0|CHEBI:132842|
Sulfasalazine (molecular entity)|Sulfasalazine||0|CHEBI:9334|
Sulfathiazole (molecular entity)|Sulfathiazole||0|CHEBI:9337|
Sulfisomidine (molecular entity)|Sulfisomidine||0|CHEBI:32166|
Sulfisoxazole (molecular entity)|Sulfisoxazole||0|CHEBI:102484|
Sulfonamide (molecular entity)|Sulfonamide||0|CHEBI:35358|An amide of a sulfonic acid.
Tedizolid (molecular entity)|Tedizolid||0|CHEBI:82717|
Tetracycline (molecular entity)|Tetracycline||0|CHEBI:27902|
Tetracycline derivative (molecular entity)|Tetracycline derivative||0|CHEBI:26895|A subclass of polyketides having an octahydrotetracene-2-carboxamide skeleton, substituted with many hydroxy and other groups.
Thiamphenicol (molecular entity)|Thiamphenicol||0|CHEBI:32215|
Thiostrepton (molecular entity)|Thiostrepton||0|CHEBI:29693|
Tigecycline (molecular entity)|Tigecycline||0|CHEBI:149836|
Tinidazole (molecular entity)|Tinidazole||0|CHEBI:63627|
Tylosin (molecular entity)|Tylosin||0|CHEBI:17658|
Viomycin (molecular entity)|Viomycin||0|CHEBI:15782|
Vancomycin(1+) (molecular entity)|Vancomycin(1+)||0|CHEBI:76842|
Viomycin(3+) (molecular entity)|Viomycin(3+)||0|CHEBI:60081|
Trovafloxacin(1+) (molecular entity)|Trovafloxacin(1+)||0|CHEBI:77569|
Topoisomerase IV inhibitor (qualifier value)|Topoisomerase IV inhibitor||0|CHEBI:53559|A topoisomerase inhibitor that inhibits DNA topoisomerase IV.
DNA synthesis inhibitor (qualifier value)|DNA synthesis inhibitor||0|CHEBI:59517|
Methanesulfonate salt (molecular entity)|Methanesulfonate salt||0|CHEBI:38037|
Imidazole (molecular entity)|Imidazole||0|CHEBI:24780|
Metronidazole(1+) (molecular entity)|Metronidazole(1+)||0|CHEBI:64682|
Cyclic peptide (molecular entity)|Cyclic peptide||0|CHEBI:23449|
Peptide (molecular entity)|Peptide||0|CHEBI:16670|
Tylosin(1+) (molecular entity)|Tylosin(1+)||0|CHEBI:77047|
Tetracycline(1-) (molecular entity)|Tetracycline(1-)||0|CHEBI:71392|
Cefadroxil(1-) (molecular entity)|Cefadroxil(1-)||0|CHEBI:53669|
Cephalothin(1-) (molecular entity)|Cephalothin(1-)||0|CHEBI:50897|
Cefoxitin(1-) (molecular entity)|Cefoxitin(1-)||0|CHEBI:53655|
Ceftazidime(1-) (molecular entity)|Ceftazidime(1-)||0|CHEBI:53676|
Ceftriaxone(1-) (molecular entity)|Ceftriaxone(1-)||0|CHEBI:53658|
Cephalexin(1-) (molecular entity)|Cephalexin(1-)||0|CHEBI:59392|
Cefamandole(1-) (molecular entity)|Cefamandole(1-)||0|CHEBI:53652|
Clavulanate (molecular entity)|Clavulanate||0|CHEBI:487869|
Colistimethate(5-) (molecular entity)|Colistimethate(5-)||0|CHEBI:59661|
Dicarboxylic acid anion (molecular entity)|Dicarboxylic acid anion||0|CHEBI:35693|
Flucloxacillin(1-) (molecular entity)|Flucloxacillin(1-)||0|CHEBI:52037|
Fusidate (molecular entity)|Fusidate||0|CHEBI:71321|
Hetacillin(1-) (molecular entity)|Hetacillin(1-)||0|CHEBI:52059|
Mandelate (molecular entity)|Mandelate||0|CHEBI:25147|
Minocycline(1-) (molecular entity)|Minocycline(1-)||0|CHEBI:71337|
Monocarboxylic acid anion (molecular entity)|Monocarboxylic acid anion||0|CHEBI:35757|
Moxifloxacinium(1+) (molecular entity)|Moxifloxacinium(1+)||0|CHEBI:63699|
Nalidixic acid anion (molecular entity)|Nalidixic acid anion||0|CHEBI:62070|
Neamine(4+) (molecular entity)|Neamine(4+)||0|CHEBI:65076|
Neomycin C(6+) (molecular entity)|Neomycin C(6+)||0|CHEBI:65077|
Novobiocin(1-) (molecular entity)|Novobiocin(1-)||0|CHEBI:71339|
Sulfacetamide(1-) (molecular entity)|Sulfacetamide(1-)||0|CHEBI:63857|
Sulfadiazinate (molecular entity)|Sulfadiazinate||0|CHEBI:33127|
Penicillinate anion (molecular entity)|Penicillinate anion||0|CHEBI:51356|
Cephalosporin carboxylic acid anion (molecular entity)|Cephalosporin carboxylic acid anion||0|CHEBI:52440|
Oxazolidine derivative (molecular entity)|Oxazolidine derivative||0|CHEBI:38329|
Deoxyribonucleic acid topoisomerase (adenosine triphosphate-hydrolysing) inhibitor (qualifier value)|Deoxyribonucleic acid topoisomerase (adenosine triphosphate-hydrolysing) inhibitor||0|CHEBI:50750|
Sotalol(1+) (molecular entity)|Sotalol(1+)||0|CHEBI:63647|
Telavancin hydrochloride (molecular entity)|Telavancin hydrochloride||0|CHEBI:71226|
Cefotiam dihydrochloride (molecular entity)|Cefotiam dihydrochloride||0|CHEBI:31374|
Ceftazidime sodium (molecular entity)|Ceftazidime sodium||0|CHEBI:53675|
(R)-timolol (molecular entity)|(R)-timolol||1|CHEBI:39466|
Alogliptin(1+) (molecular entity)|Alogliptin(1+)||0|CHEBI:72326|
Acebutolol(1+) (molecular entity)|Acebutolol(1+)||0|CHEBI:62101|
(S)-timolol hemihydrate (molecular entity)|(S)-timolol hemihydrate||1|CHEBI:60787|
(S)-timolol (anhydrous) (molecular entity)|(S)-timolol (anhydrous)||1|CHEBI:9599|
(S)-timolol maleate (molecular entity)|(S)-timolol maleate||1|CHEBI:9600|
Rosuvastatin(1-) (molecular entity)|Rosuvastatin(1-)||0|CHEBI:77313|
Pravastatin(1-) (molecular entity)|Pravastatin(1-)||0|CHEBI:63660|
Pitavastatin(1-) (molecular entity)|Pitavastatin(1-)||0|CHEBI:71260|
Levobunolol(1+) (molecular entity)|Levobunolol(1+)||0|CHEBI:72567|
Atorvastatin(1-) (molecular entity)|Atorvastatin(1-)||0|CHEBI:50690|
Carteolol(1+) (molecular entity)|Carteolol(1+)||0|CHEBI:61202|
Biguanide (molecular entity)|Biguanide||0|CHEBI:3095|
(S)-betaxolol hydrochloride (molecular entity)|(S)-betaxolol hydrochloride||1|CHEBI:59256|
(R)-betaxolol hydrochloride (molecular entity)|(R)-betaxolol hydrochloride||1|CHEBI:59255|
(R)-betaxolol (molecular entity)|(R)-betaxolol||1|CHEBI:59251|
Cerivastatin(1-) (molecular entity)|Cerivastatin(1-)||0|CHEBI:406059|
Alprenolol hydrochloride (molecular entity)|Alprenolol hydrochloride||0|CHEBI:31191|
Acebutolol (molecular entity)|Acebutolol||0|CHEBI:2379|
Acebutolol hydrochloride (molecular entity)|Acebutolol hydrochloride||0|CHEBI:2380|
Acetohexamide (molecular entity)|Acetohexamide||0|CHEBI:28052|
Alogliptin (molecular entity)|Alogliptin||0|CHEBI:72323|
Alogliptin benzoate (molecular entity)|Alogliptin benzoate||0|CHEBI:72324|
Alprenolol (molecular entity)|Alprenolol||0|CHEBI:51211|
Atenolol (molecular entity)|Atenolol||0|CHEBI:2904|
Atorvastatin (molecular entity)|Atorvastatin||0|CHEBI:39548|
Atorvastatin calcium (molecular entity)|Atorvastatin calcium||0|CHEBI:50686|
Beta 1 adrenergic antagonist (qualifier value)|Beta 1 adrenergic antagonist||0||
Beta 2 adrenergic antagonist (qualifier value)|Beta 2 adrenergic antagonist||0||
Betaxolol (molecular entity)|Betaxolol||1|CHEBI:3082|
Betaxolol hydrochloride (molecular entity)|Betaxolol hydrochloride||0|CHEBI:643228|
Bisoprolol (molecular entity)|Bisoprolol||0|CHEBI:3127|
Bisoprolol fumarate (molecular entity)|Bisoprolol fumarate||0|CHEBI:3128|
Carteolol (molecular entity)|Carteolol||0|CHEBI:3437|
Carteolol hydrochloride (molecular entity)|Carteolol hydrochloride||0|CHEBI:3438|
Carvedilol (molecular entity)|Carvedilol||0|CHEBI:3441|
Cerivastatin (molecular entity)|Cerivastatin||0|CHEBI:3558|
Cerivastatin sodium (molecular entity)|Cerivastatin sodium||0|CHEBI:3559|
Chlorpropamide (molecular entity)|Chlorpropamide||0|CHEBI:3650|
Esmolol (molecular entity)|Esmolol||0|CHEBI:4856|
Esmolol hydrochloride (molecular entity)|Esmolol hydrochloride||0|CHEBI:4857|
Fluvastatin sodium (molecular entity)|Fluvastatin sodium||0|CHEBI:5137|
Gliclazide (molecular entity)|Gliclazide||0|CHEBI:31654|
Glimepiride (molecular entity)|Glimepiride||0|CHEBI:5383|
Glipizide (molecular entity)|Glipizide||0|CHEBI:5384|
Glyburide (molecular entity)|Glyburide||0|CHEBI:5441|
Labetalol (molecular entity)|Labetalol||0|CHEBI:6343|
(S)-betaxolol (molecular entity)|(S)-betaxolol||1|CHEBI:59254|
Levobunolol (molecular entity)|Levobunolol||0|CHEBI:6438|
Levobunolol hydrochloride (molecular entity)|Levobunolol hydrochloride||0|CHEBI:6439|
Linagliptin (molecular entity)|Linagliptin||0|CHEBI:68610|
Lovastatin (molecular entity)|Lovastatin||0|CHEBI:40303|
Metformin (molecular entity)|Metformin||0|CHEBI:6801|
Metipranolol (molecular entity)|Metipranolol||0|CHEBI:6897|
Metipranolol hydrochloride (molecular entity)|Metipranolol hydrochloride||0|CHEBI:34845|
Metoprolol (molecular entity)|Metoprolol||0|CHEBI:6904|
Nonselective beta adrenergic antagonist (qualifier value)|Nonselective beta adrenergic antagonist||0||
Pindolol (molecular entity)|Pindolol||0|CHEBI:8214|
Pitavastatin (molecular entity)|Pitavastatin||0|CHEBI:32020|
Pitavastatin calcium (molecular entity)|Pitavastatin calcium||0|CHEBI:71258|
Practolol (molecular entity)|Practolol||0|CHEBI:258351|
Pravastatin (molecular entity)|Pravastatin||0|CHEBI:63618|
Pravastatin sodium (molecular entity)|Pravastatin sodium||0|CHEBI:8361|
Propranolol (molecular entity)|Propranolol||0|CHEBI:8499|
Propranolol hydrochloride (molecular entity)|Propranolol hydrochloride||0|CHEBI:8500|
Rosuvastatin (molecular entity)|Rosuvastatin||0|CHEBI:38545|
Rosuvastatin calcium (molecular entity)|Rosuvastatin calcium||0|CHEBI:77249|
Saxagliptin (molecular entity)|Saxagliptin||0|CHEBI:71272|
Simvastatin (molecular entity)|Simvastatin||0|CHEBI:9150|
Sitagliptin (molecular entity)|Sitagliptin||0|CHEBI:40237|
Sotalol (molecular entity)|Sotalol||0|CHEBI:63622|
Sotalol hydrochloride (molecular entity)|Sotalol hydrochloride||0|CHEBI:9207|
N-sulfonylurea (molecular entity)|N-sulfonylurea||0|CHEBI:76983|A urea in which one of the hydrogens attached to a nitrogen of the urea group is replaced by a sulfonyl group.
Timolol (molecular entity)|Timolol||0|CHEBI:39465|
Tolazamide (molecular entity)|Tolazamide||0|CHEBI:9613|
Tolbutamide (molecular entity)|Tolbutamide||0|CHEBI:27999|
Beta adrenergic antagonist (qualifier value)|Beta adrenergic antagonist||0|CHEBI:35530|
Dipeptidyl peptidase IV inhibitor (qualifier value)|Dipeptidyl peptidase IV inhibitor||0|CHEBI:68612|A dipeptidyl- and tripeptidyl-peptidase inhibitor that specifically inhibits dipeptidyl peptidase-4.
Hydroxymethylglutaryl-CoA reductase inhibitor (qualifier value)|HMG-CoA reductase inhibitor|Hydroxymethylglutaryl-CoA reductase inhibitor|1|CHEBI:35664|
Nitrile (molecular entity)|Nitrile||0|CHEBI:18379|
Benzoate salt (molecular entity)|Benzoate salt||0|CHEBI:72325|
Aadamantane derivative (molecular entity)|Aadamantane derivative||0|CHEBI:51339|Compounds containing an adamantane skeleton.
Alcohol (molecular entity)|Alcohol||0|CHEBI:30879|A compound in which a hydroxy group is attached to a saturated carbon atom.
Alpha-glucoside inhibitor (qualifier value)|Alpha-glucoside inhibitor||0|CHEBI:67239|
Azabicycloalkane (molecular entity)|Azabicycloalkane||0|CHEBI:38295|
Monocarboxylic acid amide (molecular entity)|Monocarboxylic acid amide||0|CHEBI:29347|A carboxamide derived from a monocarboxylic acid.
Pyrimidine derivative (molecular entity)|Pyrimidine derivative||0|CHEBI:39447|Any compound having a pyrimidine as part of its structure.
Quinazoline (molecular entity)|Quinazoline||0|CHEBI:38530|Any organic heterobicyclic compound based on a quinazoline skeleton and its substituted derivatives.
Calcium salt (molecular entity)|Calcium salt||0|CHEBI:51031|
Cyanide derivative (molecular entity)|Cyanide derivative||0|CHEBI:23424|
Amide (molecular entity)|Amide||0|CHEBI:32988|
Adrenergic antagonist (qualifier value)|Adrenergic antagonist||0|CHEBI:37887|
Adrenergic (qualifier value)|Adrenergic||0|CHEBI:37962|
Ethylenediamine derivative (molecular entity)|Ethylenediamine derivative||0|CHEBI:4877|Any organic amino compound that is a derivative of ethylenediamine.
(2R,4S)-terconazole (molecular entity)|(2R,4S)-terconazole||1|CHEBI:82980|
(2S,4R)-terconazole (molecular entity)|(2S,4R)-terconazole||1|CHEBI:82981|
(R)-bambuterol (molecular entity)|(R)-bambuterol||1|CHEBI:59179|
(R)-bambuterol hydrochloride (molecular entity)|(R)-bambuterol hydrochloride||1|CHEBI:59182|
(R)-bifonazole (molecular entity)|(R)-bifonazole||1|CHEBI:78693|
(R)-clenbuterol (molecular entity)|(R)-clenbuterol||1|CHEBI:59567|
(R)-eberconazole (molecular entity)|(R)-eberconazole||1|CHEBI:83587|
(R)-eberconazole(1+) (molecular entity)|(R)-eberconazole(1+)||1|CHEBI:83597|
(R)-econazole (molecular entity)|(R)-econazole||1|CHEBI:82877|
(R)-econazole nitrate (molecular entity)|(R)-econazole nitrate||1|CHEBI:82870|
(R)-fenticonazole (molecular entity)|(R)-fenticonazole||1|CHEBI:83604|
(R)-fenticonazole nitrate (molecular entity)|(R)-fenticonazole nitrate||1|CHEBI:83608|
(R)-fenticonazole(1+) (molecular entity)|(R)-fenticonazole(1+)||1|CHEBI:83611|
(R)-isoconazole (molecular entity)|(R)-isoconazole||1|CHEBI:83666|
(R)-miconazole (molecular entity)|(R)-miconazole||1|CHEBI:82894|
(R)-miconazole nitrate (molecular entity)|(R)-miconazole nitrate||1|CHEBI:82886|
(R)-nisoldipine (molecular entity)|(R)-nisoldipine||1|CHEBI:76918|
(R)-omeprazole (molecular entity)|(R)-omeprazole||1|CHEBI:77262|
(R)-salmeterol (molecular entity)|(R)-salmeterol||1|CHEBI:64062|
(R)-sulconazole (molecular entity)|(R)-sulconazole||1|CHEBI:77777|
(R)-tioconazole (molecular entity)|(R)-tioconazole||1|CHEBI:77905|
(S)-bambuterol (molecular entity)|(S)-bambuterol||1|CHEBI:59180|
(S)-bambuterol hydrochloride (molecular entity)|(S)-bambuterol hydrochloride||1|CHEBI:59183|
(S)-clenbuterol (molecular entity)|(S)-clenbuterol||1|CHEBI:59568|
(S)-eberconazole (molecular entity)|(S)-eberconazole||1|CHEBI:83588|
(S)-eberconazole(1+) (molecular entity)|(S)-eberconazole(1+)||1|CHEBI:83596|
(S)-econazole (molecular entity)|(S)-econazole||1|CHEBI:82872|
(S)-econazole nitrate (molecular entity)|(S)-econazole nitrate||1|CHEBI:82871|
(S)-fenticonazole (molecular entity)|(S)-fenticonazole||1|CHEBI:83603|
(S)-fenticonazole nitrate (molecular entity)|(S)-fenticonazole nitrate||1|CHEBI:83607|
(S)-fenticonazole(1+) (molecular entity)|(S)-fenticonazole(1+)||1|CHEBI:83614|
(S)-isoconazole (molecular entity)|(S)-isoconazole||1|CHEBI:83668|
(S)-miconazole (molecular entity)|(S)-miconazole||1|CHEBI:82897|
(S)-miconazole nitrate (molecular entity)|(S)-miconazole nitrate||1|CHEBI:82888|
(S)-nisoldipine (molecular entity)|(S)-nisoldipine||1|CHEBI:76919|
(S)-salmeterol (molecular entity)|(S)-salmeterol||1|CHEBI:64063|
(S)-sertaconazole (molecular entity)|(S)-sertaconazole||1|CHEBI:83684|
(S)-sertaconazole nitrate (molecular entity)|(S)-sertaconazole nitrate||1|CHEBI:83691|
(S)-sertaconazole(1+) (molecular entity)|(S)-sertaconazole(1+)||1|CHEBI:83698|
(S)-sulconazole (molecular entity)|(S)-sulconazole||1|CHEBI:77778|
(S)-tioconazole (molecular entity)|(S)-tioconazole||1|CHEBI:77903|
(S)-verapamil (molecular entity)|(S)-verapamil||1|CHEBI:77736|
(S)-verapamil hydrochloride (molecular entity)|(S)-verapamil hydrochloride||1|CHEBI:77741|
(S)-verapamil(1+) (molecular entity)|(S)-verapamil(1+)||1|CHEBI:77738|
Arasertaconazole (molecular entity)|Arasertaconazole||0|CHEBI:83685|
Arasertaconazole nitrate (molecular entity)|Arasertaconazole nitrate||0|CHEBI:83692|
(S)-bifonazole (molecular entity)|(S)-bifonazole||1|CHEBI:78694|
Dexverapamil (molecular entity)|Dexverapamil||0|CHEBI:77734|
Dexverapamil hydrochloride (molecular entity)|Dexverapamil hydrochloride||0|CHEBI:77739|
Dexverapamil(1+) (molecular entity)|Dexverapamil(1+)||0|CHEBI:77737|
Esomeprazole(1-) (molecular entity)|Esomeprazole(1-)||0|CHEBI:77264|
Famotidine hydrochloride (molecular entity)|Famotidine hydrochloride||0|CHEBI:50377|
Fosinopril(1-) (molecular entity)|Fosinopril(1-)||0|CHEBI:59125|
Indacaterol(1+) (molecular entity)|Indacaterol(1+)||0|CHEBI:68574|
Oxiconazole(1+) (molecular entity)|Oxiconazole(1+)||0|CHEBI:77698|
Pantoprazole(1-) (molecular entity)|Pantoprazole(1-)||0|CHEBI:50358|
Perindopril(1-) (molecular entity)|Perindopril(1-)||0|CHEBI:78000|
Rabeprazole(1-) (molecular entity)|Rabeprazole(1-)||0|CHEBI:49199|
Ramiprilat (molecular entity)|Ramiprilat||0|CHEBI:77363|
Vilanterol(1+) (molecular entity)|Vilanterol(1+)||0|CHEBI:75039|
Zofenoprilat(1-) (molecular entity)|Zofenoprilat(1-)||0|CHEBI:82604|
Salbutamol (molecular entity)|Salbutamol|Albuterol|0|CHEBI:2549|
Alfuzosin (molecular entity)|Alfuzosin||0|CHEBI:51141|
Alfuzosin hydrochloride (molecular entity)|Alfuzosin hydrochloride||0|CHEBI:32286|
Alpha 1 adrenergic antagonist (qualifier value)|Alpha 1 adrenergic antagonist||0||An agent that binds to but does not activate alpha 1 adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists.
Alpha 2 adrenergic antagonist (qualifier value)|Alpha 2 adrenergic antagonist||0||An agent that binds to but does not activate alpha 2 adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists.
Amlodipine (molecular entity)|Amlodipine||0|CHEBI:2668|
Amlodipine besilate (molecular entity)|Amlodipine besilate||0|CHEBI:2669|
Arformoterol (molecular entity)|Arformoterol||0|CHEBI:408174|
Azilsartan (molecular entity)|Azilsartan||0|CHEBI:68850|
Azilsartan medoxomil (molecular entity)|Azilsartan medoxomil||0|CHEBI:68845|
Bambuterol (molecular entity)|Bambuterol||0|CHEBI:553827|
Bambuterol hydrochloride (molecular entity)|Bambuterol hydrochloride||0|CHEBI:59167|
Benazepril (molecular entity)|Benazepril||0|CHEBI:3011|
Benzothiazepine (molecular entity)|Benzothiazepine||0|CHEBI:48684|
Bepridil (molecular entity)|Bepridil||0|CHEBI:3061|
Bepridil hydrochloride (molecular entity)|Bepridil hydrochloride||0|CHEBI:52712|
Candesartan (molecular entity)|Candesartan||0|CHEBI:3347|
Captopril (molecular entity)|Captopril||0|CHEBI:3380|
Cimetidine (molecular entity)|Cimetidine||0|CHEBI:3699|
Cimetidine hydrochloride (molecular entity)|Cimetidine hydrochloride||0|CHEBI:50362|
Clenbuterol (molecular entity)|Clenbuterol||0|CHEBI:174690|
Clotrimazole (molecular entity)|Clotrimazole||0|CHEBI:3764|
Dapiprazole (molecular entity)|Dapiprazole||0|CHEBI:51066|
Dihydro-alpha-ergocryptine mesylate (molecular entity)|Dihydro-alpha-ergocryptine mesylate||0|CHEBI:31487|
Dihydro-beta-ergocryptine mesylate (molecular entity)|Dihydro-beta-ergocryptine mesylate||0|CHEBI:34704|
Dihydroergocornine mesylate (molecular entity)|Dihydroergocornine mesylate||0|CHEBI:34502|
Dihydroergocristine (molecular entity)|Dihydroergocristine||0|CHEBI:59912|
Dihydroergocristine mesylate (molecular entity)|Dihydroergocristine mesylate||0|CHEBI:31490|
Diltiazem hydrochloride (molecular entity)|Diltiazem hydrochloride||0|CHEBI:645509|
Doxazosin (molecular entity)|Doxazosin||0|CHEBI:4708|
Doxazosin mesylate (molecular entity)|Doxazosin mesylate||0|CHEBI:4709|
Efinaconazole (molecular entity)|Efinaconazole||0|CHEBI:82718|
Enalapril (molecular entity)|Enalapril||0|CHEBI:4784|
Enalapril maleate (molecular entity)|Enalapril maleate||0|CHEBI:4785|
Enalaprilat (molecular entity)|Enalaprilat||0|CHEBI:4786|
Eprosartan (molecular entity)|Eprosartan||0|CHEBI:4814|
Eprosartan mesylate (molecular entity)|Eprosartan mesylate||0|CHEBI:48409|
Esomeprazole (molecular entity)|Esomeprazole||0|CHEBI:50275|
Esomeprazole magnesium (molecular entity)|Esomeprazole magnesium||0|CHEBI:50309|
Famotidine (molecular entity)|Famotidine||0|CHEBI:4975|
Felodipine (molecular entity)|Felodipine||0|CHEBI:585948|
Fenoterol (molecular entity)|Fenoterol||0|CHEBI:149226|
Fluconazole (molecular entity)|Fluconazole||0|CHEBI:46081|
Flutrimazole (molecular entity)|Flutrimazole||0|CHEBI:82864|
Fosinopril (molecular entity)|Fosinopril||0|CHEBI:5163|
Fosinopril sodium (molecular entity)|Fosinopril sodium||0|CHEBI:5164|
Indacaterol (molecular entity)|Indacaterol||0|CHEBI:68575|
Indacaterol maleate (molecular entity)|Indacaterol maleate||0|CHEBI:68573|
Irbesartan (molecular entity)|Irbesartan||0|CHEBI:5959|
Itraconazole (molecular entity)|Itraconazole||0|CHEBI:6076|
Ketoconazole (molecular entity)|Ketoconazole||0|CHEBI:48339|
Lansoprazole (molecular entity)|Lansoprazole||0|CHEBI:6375|
(R)-salbutamol (molecular entity)|(R)-salbutamol|Levalbuterol|1|CHEBI:8746|
Lisinopril (molecular entity)|Lisinopril||0|CHEBI:43755|
Losartan (molecular entity)|Losartan||0|CHEBI:6541|
Nifedipine (molecular entity)|Nifedipine||0|CHEBI:7565|
Nimodipine (molecular entity)|Nimodipine||0|CHEBI:7575|
Nisoldipine (molecular entity)|Nisoldipine||0|CHEBI:7577|
Nitrendipine (molecular entity)|Nitrendipine||0|CHEBI:7582|
Nizatidine (molecular entity)|Nizatidine||0|CHEBI:7601|
Nonselective alpha adrenergic antagonist (qualifier value)|Nonselective alpha adrenergic antagonist||0||
Olmesartan (molecular entity)|Olmesartan||0|CHEBI:48416|
Olodaterol (molecular entity)|Olodaterol||0|CHEBI:82700|
Olodaterol hydrochloride (molecular entity)|Olodaterol hydrochloride||0|CHEBI:83309|
Oxiconazole (molecular entity)|Oxiconazole||0|CHEBI:7825|
Oxiconazole nitrate (molecular entity)|Oxiconazole nitrate||0|CHEBI:7826|
Pantoprazole (molecular entity)|Pantoprazole||0|CHEBI:7915|
Pantoprazole sodium (molecular entity)|Pantoprazole sodium||0|CHEBI:50270|
Perhexiline (molecular entity)|Perhexiline||0|CHEBI:35553|
Perindopril (molecular entity)|Perindopril||0|CHEBI:8024|
Perindopril arginine (molecular entity)|Perindopril arginine||0|CHEBI:77655|
Phentolamine (molecular entity)|Phentolamine||0|CHEBI:8081|
Posaconazole (molecular entity)|Posaconazole||0|CHEBI:64355|
Prazosin (molecular entity)|Prazosin||0|CHEBI:8364|
Prazosin hydrochloride (molecular entity)|Prazosin hydrochloride||0|CHEBI:8365|
Quinapril (molecular entity)|Quinapril||0|CHEBI:8713|
Quinapril hydrochloride (molecular entity)|Quinapril hydrochloride||0|CHEBI:8714|
Rabeprazole (molecular entity)|Rabeprazole||0|CHEBI:8768|
Rabeprazole sodium (molecular entity)|Rabeprazole sodium||0|CHEBI:8769|
Ramipril (molecular entity)|Ramipril||0|CHEBI:8774|
Ranitidine (molecular entity)|Ranitidine||0|CHEBI:8776|
Ranitidine hydrochloride (molecular entity)|Ranitidine hydrochloride||0|CHEBI:8777|
Fenoterol hydrobromide (molecular entity)|Fenoterol hydrobromide||0|CHEBI:31601|
Tamsulosin (molecular entity)|Tamsulosin||0|CHEBI:9398|
Tamsulosin hydrochloride (molecular entity)|Tamsulosin hydrochloride||0|CHEBI:9399|
Telmisartan (molecular entity)|Telmisartan||0|CHEBI:9434|
Terazosin hydrochloride dihydrate (molecular entity)|Terazosin hydrochloride dihydrate||0|CHEBI:9446|
Terazosin (molecular entity)|Terazosin||0|CHEBI:9445|
Terbutaline (molecular entity)|Terbutaline||0|CHEBI:9449|
Tolazoline (molecular entity)|Tolazoline||0|CHEBI:28502|
Valsartan (molecular entity)|Valsartan||0|CHEBI:9927|
Verapamil hydrochloride (molecular entity)|Verapamil hydrochloride||0|CHEBI:53188|
Vilanterol (molecular entity)|Vilanterol||0|CHEBI:75037|
Vilanterol trifenate (molecular entity)|Vilanterol trifenate||0|CHEBI:75040|
Voriconazole (molecular entity)|Voriconazole||0|CHEBI:10023|
Yohimbine (molecular entity)|Yohimbine||0|CHEBI:10093|
Zofenopril (molecular entity)|Zofenopril||0|CHEBI:78539|
Zofenopril calcium (molecular entity)|Zofenopril calcium||0|CHEBI:82600|
Zofenoprilat (molecular entity)|Zofenoprilat||0|CHEBI:82602|
Zofenoprilat arginine (molecular entity)|Zofenoprilat arginine||0|CHEBI:82603|
Furan (molecular entity)|Furan||0|CHEBI:24129|Compounds containing at least one furan ring.
H2-receptor antagonist (qualifier value)|H2-receptor antagonist||0|CHEBI:37961|Compounds that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of endogenous histamine.
Apoptosis inhibitor (qualifier value)|Apoptosis inhibitor||0|CHEBI:68494|Any substance that inhibits the process of apoptosis (programmed cell death) in multi-celled organisms.
Alpha adrenergic antagonist (qualifier value)|Alpha adrenergic antagonist||0||
Triazole (molecular entity)|Triazole||0|CHEBI:35727|
Nitrate salt (molecular entity)|Nitrate salt||0||
(R)-isoconazole(1+) (molecular entity)|(R)-isoconazole(1+)||1|CHEBI:83674|
(S)-isoconazole(1+) (molecular entity)|(S)-isoconazole(1+)||1|CHEBI:83673|
(R)-isoconazole nitrate (molecular entity)|(R)-isoconazole nitrate||1|CHEBI:83669|
(S)-isoconazole nitrate (molecular entity)|(S)-isoconazole nitrate||1|CHEBI:83671|
Magnesium salt (molecular entity)|Magnesium salt||0|CHEBI:33975|
(S)-eberconazole nitrate (molecular entity)|(S)-eberconazole nitrate||1|CHEBI:83595|
(R)-eberconazole nitrate (molecular entity)|(R)-eberconazole nitrate||1||
Arasertaconazole(1+) (molecular entity)|Arasertaconazole(1+)||0|CHEBI:83692|
Cytochrome P450 inhibitor (qualifier value)|Cytochrome P450 inhibitor||0|CHEBI:50183|
Dioxolane (molecular entity)|Dioxolane||0|CHEBI:39430|
Ammonium salt (molecular entity)|Ammonium salt||0|CHEBI:46850|
Beta adrenergic agonist (qualifier value)|Beta adrenergic agonist||0|CHEBI:35522|An agent that selectively binds to and activates beta adrenergic receptors.
Adrenergic agonist (qualifier value)|Adrenergic agonist||0|CHEBI:37886|An agent that selectively binds to and activates adrenergic receptors.
Beta 1 adrenergic agonist (qualifier value)|Beta 1 adrenergic agonist||0||An agent that selectively binds to and activates beta 1 adrenergic receptors.
Beta 2 adrenergic agonist (qualifier value)|Beta 2 adrenergic agonist||0||An agent that selectively binds to and activates beta 2 adrenergic receptors.
Nonselective beta adrenergic agonist (qualifier value)|Nonselective beta adrenergic agonist||0||
(R)-orciprenaline (molecular entity)|(R)-orciprenaline||1|CHEBI:83330|
(S)-orciprenaline (molecular entity)|(S)-orciprenaline||1|CHEBI:83331|
(S)-orciprenaline(1+) (molecular entity)|(S)-orciprenaline(1+)||1|CHEBI:83338|
(R)-orciprenaline(1+) (molecular entity)|(R)-orciprenaline(1+)||1|CHEBI:83340|
(R)-orciprenaline sulfate (molecular entity)|(R)-orciprenaline sulfate||1|CHEBI:83333|
(S)-orciprenaline sulfate (molecular entity)|(S)-orciprenaline sulfate||1|CHEBI:83337|
Mirabegron (molecular entity)|Mirabegron||0|CHEBI:65349|
Isoprenaline|Isoprenaline||0|CHEBI:64317|
(R)-bitolterol (molecular entity)|(R)-bitolterol||1|CHEBI:59188|
(S)-bitolterol (molecular entity)|(S)-bitolterol||1|CHEBI:59189|
(R)-bitolterol mesylate (molecular entity)|(R)-bitolterol mesylate||1|CHEBI:59190|
(S)-bitolterol mesylate (molecular entity)|(S)-bitolterol mesylate||1|CHEBI:59191|
Phenol derivative (molecular entity)|Phenol derivative||0|CHEBI:33853|Organic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
Ethanolamine derivative (molecular entity)|Ethanolamine derivative||0|CHEBI:23981|
Arformoterol(1+) (molecular entity)|Arformoterol(1+)||0|CHEBI:63107|
Bitolterol (molecular entity)|Bitolterol||0|CHEBI:3133|
Bitolterol mesylate (molecular entity)|Bitolterol mesylate||0|CHEBI:3134|
(S,S)-formoterol(1+) (molecular entity)|(S,S)-formoterol(1+)||1|CHEBI:63110|
(S,S)-formoterol (molecular entity)|(S,S)-formoterol||1|CHEBI:63081|
(S,S)-formoterol fumarate (molecular entity)|(S,S)-formoterol fumarate||1|CHEBI:63109|
Arformoterol fumarate (molecular entity)|Arformoterol fumarate||0|CHEBI:63108|
Sympathomimetic (qualifier value)|Sympathomimetic||0|CHEBI:35524|
Bromide salt (molecular entity)|Bromide salt||0|CHEBI:22925|
Hormone antagonist (qualifier value)|Hormone antagonist||0|CHEBI:49020|A chemical substance which inhibits the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
Angiotensin receptor antagonist|Angiotensin receptor antagonist||0|CHEBI:61016|A hormone antagonist that blocks angiotensin receptors.
Angiotensin II receptor antagonist (qualifier value)|Angiotensin II receptor antagonist||0||
Beta 3 adrenergic agonist (qualifier value)|Beta 3 adrenergic agonist||0||An agent that selectively binds to and activates beta 3 adrenergic receptors.
Dihydropyridine (molecular entity)|Dihydropyridine||0|CHEBI:50075|
Steroid acid anion (molecular entity)|Steroid acid anion||0|CHEBI:50160|
Amino alcohol (molecular entity)|Amino alcohol||0|CHEBI:22478|An alcohol containing an amino functional group in addition to the alcohol-defining hydroxy group.
Propanolamine (molecular entity)|Propanolamine||0|CHEBI:35533|
Sympatholytic (qualifier value)|Sympatholytic||0|CHEBI:66991|
Bromine compound|Bromine compound||0|CHEBI:37141|A compound containing at least one carbon-bromine bond.
Tetrazole (molecular entity)|Tetrazole||0|CHEBI:35689|An azole in which the five-membered heterocyclic aromatic skeleton contains four N atoms and one C atom.
Zofenopril(1-) (molecular entity)|Zofenopril(1-)||0|CHEBI:82601|
Fatty acid ester (molecular entity)|Fatty acid ester||0|CHEBI:35748|
Ergot alkaloid (molecular entity)|Ergot alkaloid||0|CHEBI:23943|
Indole derivative (molecular entity)|Indole derivative||0|CHEBI:24828|Any compound containing an indole skeleton.
Proline derivative (molecular entity)|Proline derivative||0|CHEBI:26273|
Dipeptide (molecular entity)|Dipeptide||0|CHEBI:46761|
Isoquinoline (molecular entity)|Isoquinoline||0|CHEBI:24922|A compound consisting of isoquinoline and its substitution derivatives.
Chlorine compound (molecular entity)|Chlorine compound||0|CHEBI:36683|
Benzocycloheptapyridine (molecular entity)|Benzocycloheptapyridine||0|CHEBI:48593|